TELETRADER News
11/30/2021, 1:22 AM (Source: TeleTrader)
more TeleTrader news

Pfizer-1.46%

54.14
Chart for: Pfizer Inc

Pfizer to seek approval for booster for ages 16,17 in US - reports

Pfizer Inc. will apply for authorization for its booster COVID-19 vaccine for ages 16 and 17 in the United States, US media reported. Health officials in the US currently recommend that all people over 18 get the booster in light of the emergence of the Omicron variant.

Sources stated the company is expected to seek authorization "in the coming days." Pfizer's partner BioNTech stated on Friday it is testing the effectiveness of their shot against Omicron, estimating it could deliver vaccines adapted to the new variant within 100 days.

Baha Breaking the News (BBN) / DJ